Literature DB >> 24876185

Hospitalisation and comorbidities in Parkinson's disease: a large Australian retrospective study.

Michal Lubomski1, R Louise Rushworth2, Stephen Tisch1.   

Abstract

OBJECTIVES: Patients with Parkinson's disease (PD) require higher levels of care during hospitalisation. Management of comorbidities in these patients aims to optimise function while minimising complications. The objective of this study was to examine patterns of hospitalisation of patients with PD in NSW with regards to sociodemographic factors, comorbidities and aspects of clinical management.
METHODS: A retrospective study of all patients with idiopathic PD and a control group of non-PD patients admitted for acute care to NSW hospitals between 2008 and 2012.
RESULTS: The study group comprised 5637 cases and 8143 controls. The mean PD patient age was 75.0 years (±10.9). Patients with PD had a significantly longer hospital stay (median 7 days, IQR 3-13 vs 1 day, IQR 1-7, p<0.001) than control patients. Patients with PD were five times more likely to be treated for delirium, three times more likely to experience an adverse drug event and syncope, more than twice as likely to require management of falls/fractures, dementia, gastrointestinal complications, genitourinary infections, reduced mobility and other trauma but half as likely to require hospitalisation for chronic airways disease and neoplasia, including melanoma, than the control group (all p<0.001).
CONCLUSIONS: Patients with PD are more likely to suffer serious health problems, including delirium, adverse drug reactions, syncope, falls and fractures than controls. These findings highlight PD as a multisystem neuropsychiatric disorder in which motor and non-motor features contribute to morbidity. Increased awareness of the added risk PD poses in acute hospitalised patients can be used to inform strategies to improve patient outcomes. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Parkinson's Disease

Mesh:

Year:  2014        PMID: 24876185     DOI: 10.1136/jnnp-2014-307822

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  30 in total

1.  Gastrointestinal dysfunction in Parkinson's disease.

Authors:  Michal Lubomski; Ryan L Davis; Carolyn M Sue
Journal:  J Neurol       Date:  2020-01-27       Impact factor: 4.849

2.  Comprehensive risk factor evaluation of postoperative delirium following major surgery: clinical data warehouse analysis.

Authors:  Suk Yun Kang; Sang Won Seo; Joo Yong Kim
Journal:  Neurol Sci       Date:  2019-01-24       Impact factor: 3.307

3.  Evaluating Outcomes for Older Patients with Parkinson's Disease or Dementia with Lewy Bodies who have been Hospitalised for Hip Fracture Surgery: Potential Impact of Drug Administration.

Authors:  Marie Enemark; Mette Midttun; Kristian Winge
Journal:  Drugs Aging       Date:  2017-05       Impact factor: 3.923

4.  Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders.

Authors:  Stella M Papa; Patrik Brundin; Victor S C Fung; Un Jung Kang; David J Burn; Carlo Colosimo; Han-Lin Chiang; Roy N Alcalay; Claudia Trenkwalder
Journal:  Mov Disord       Date:  2020-04-16       Impact factor: 10.338

5.  Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders.

Authors:  Stella M Papa; Patrik Brundin; Victor S C Fung; Un Jung Kang; David J Burn; Carlo Colosimo; Han-Lin Chiang; Roy N Alcalay; Claudia Trenkwalder
Journal:  Mov Disord Clin Pract       Date:  2020-04-16

6.  Identification of fall predictors in the active elderly population from the routine medical records of general practitioners.

Authors:  Vieri Lastrucci; Chiara Lorini; Giada Rinaldi; Guglielmo Bonaccorsi
Journal:  Prim Health Care Res Dev       Date:  2017-09-05       Impact factor: 1.458

Review 7.  Palliative care for Parkinson's disease: has the time come?

Authors:  Janis M Miyasaki; Benzi Kluger
Journal:  Curr Neurol Neurosci Rep       Date:  2015-05       Impact factor: 5.081

Review 8.  Hallucinations, somatic-functional disorders of PD-DLB as expressions of thalamic dysfunction.

Authors:  Marco Onofrj; Alberto J Espay; Laura Bonanni; Stefano Delli Pizzi; Stefano L Sensi
Journal:  Mov Disord       Date:  2019-07-15       Impact factor: 10.338

Review 9.  Review of delirium in patients with Parkinson's disease.

Authors:  Emma R L C Vardy; Andrew Teodorczuk; Alison J Yarnall
Journal:  J Neurol       Date:  2015-05-10       Impact factor: 4.849

Review 10.  Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

Authors:  Anna Chang; Susan H Fox
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.